Therefore, the activated Ifng/Cxcl9 axis stimulated by SRC-3 KO Tregs would be expected to suppress WT Tregs in breast tumors by enhancing Ifng-induced cellular fragility in WT Tregs. The gene discussed is CXCL9; the disease is breast neoplasm.